Determinants of time to medication optimisation in heart failure with reduced ejection fraction: a real-world tertiary centre cohort

11 May 2026 (11:04 - 12:21)

Organised by:

Abstract

Sign in to view the resources

Slides

About the speaker

Doctor Greg Douglas

Beaumont Hospital, Dublin 9 (Ireland)

6 More presentations in this session

Presentation thumbnail

Mineralocorticoid receptor antagonist use in chronic heart failure: a real-world analysis focused on preserved ejection fraction and safety outcomes

Doctor N. Montufar (Jaen, ES)

Abstract Slides

Presentation thumbnail

Four pillars, uneven foundations: Impact of multimorbidity on guideline-directed medical therapy optimisation in a tertiary heart failure unit

Doctor G. Douglas (Dublin 9, IE)

Abstract Slides

Presentation thumbnail

Association of over-the-counter magnesium supplementation with heart failure-related clinical worsening in heart failure with preserved ejection fraction

Associate Professor A. Sahin (Canakkale, TR)

Abstract Slides

Presentation thumbnail

Continuous vs intermittent loop diuretics in acute Heart Failure (DIUR-AHF): a propensity matched analysis

Doctor G. Ruocco (Maastricht, NL)

Abstract Slides

Presentation thumbnail

Determinants of long-term survival in the guideline-directed era: real-world evidence on pharmacological persistence and up-titration

Miss E. Mendoza (MX)

Abstract Slides

Access the full session

Session thumbnail

ePosters in chronic heart failure - pharmacotherapy (7)

The Event

Event poster

Heart Failure 2026

11 May 2026 11:04 CET

You may be interested in

Congress Session

Guideline-directed medical therapy implementation in special clinical scenarios

Congress Presentation

Audience Q&A

Congress Session

Meet the Experts: summation of the science - treatment of chronic heart failure in 2023

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources